TheraRadar
← Back
Data updated: Jul 17, 2026

CIS

Pharma
Pharmaceuticals

CIS is a pharmaceutical company with 1 FDA-approved products.

1976
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules

CIS's Key Drugs

CIS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CIS's Recent FDA Approvals

New NDA/BLA approvals for CIS over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

CIS's Therapeutic Areas

Disease areas where CIS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

CIS Pipeline Snapshot

Active clinical trials for CIS across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling